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Abstract
We tested the hypothesis that Crohn’s disease (CD)-related genetic polymorphisms involved in host innate immunity are
associated with shifts in human ileum–associated microbial composition in a cross-sectional analysis of human ileal samples.
Sanger sequencing of the bacterial 16S ribosomal RNA (rRNA) gene and 454 sequencing of 16S rRNA gene hypervariable
regions (V1–V3 and V3–V5), were conducted on macroscopically disease-unaffected ileal biopsies collected from 52 ileal CD,
58 ulcerative colitis and 60 control patients without inflammatory bowel diseases (IBD) undergoing initial surgical resection.
These subjects also were genotyped for the three major NOD2 risk alleles (Leu1007fs, R708W, G908R) and the ATG16L1 risk
allele (T300A). The samples were linked to clinical metadata, including body mass index, smoking status and Clostridia
difficile infection. The sequences were classified into seven phyla/subphyla categories using the Naı ¨ve Bayesian Classifier of
the Ribosome Database Project. Centered log ratio transformation of six predominant categories was included as the
dependent variable in the permutation based MANCOVA for the overall composition with stepwise variable selection.
Polymerase chain reaction (PCR) assays were conducted to measure the relative frequencies of the Clostridium coccoides –
Eubacterium rectales group and the Faecalibacterium prausnitzii spp. Empiric logit transformations of the relative frequencies
of these two microbial groups were included in permutation-based ANCOVA. Regardless of sequencing method, IBD
phenotype, Clostridia difficile and NOD2 genotype were selected as associated (FDR #0.05) with shifts in overall microbial
composition. IBD phenotype and NOD2 genotype were also selected as associated with shifts in the relative frequency of
the C. coccoides – E. rectales group. IBD phenotype, smoking and IBD medications were selected as associated with shifts in
the relative frequency of F. prausnitzii spp. These results indicate that the effects of genetic and environmental factors on
IBD are mediated at least in part by the enteric microbiota.
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Introduction
Abnormal host-microbial interactions and genetic susceptibility
are implicated in the pathogenesis of inflammatory bowel diseases
(IBD) [1–4]. Culture-independent microbiological technologies
coupled with high-throughput DNA sequencing have revolution-
ized the scale, speed, and economics of microbial ecological
studies. When applied to IBD, these technologies have uncovered
alterations in human intestine-associated microbial compositions
(‘‘dysbiosis’’) in IBD patients compared with controls [5–12]. To
further investigate mechanisms and the biological and clinical
significance of dysbiosis in IBD, we have begun integrating
metagenomic and phenotype data with genotype and additional
clinical metadata.
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e26284We focused on the three prevalent risk alleles of the nucleotide
oligomerization domain 2 (NOD2; Leu1007fs, R702W, and
G908R) and the ATG16L1 T300A genotype out of the ,100
IBD related genotypes identified thus far, because these loci have
been linked to host innate immunity, particularly Paneth cell
function, and ileal Crohn’s disease (CD) phenotype [13–27]. We
recently conducted an exploratory study that integrated NOD2
and ATG16L1 genotype data with a previously published 16S
rRNA sequence dataset [5,11]. This analysis revealed potential
associations between alterations in intestine-associated microbial
composition and respectively disease phenotype, NOD2 and
ATG16L1 genotype. One limitation was that the samples from
IBD patients were collected from two separate anatomic sites
(ileum and colon), and from both grossly disease-affected and
disease unaffected regions. The CD patients were heterogeneous
with respect to disease location and included patients with both
ileal and colonic disease. There is evidence that patients with
isolated colonic CD have distinct genetic characteristics from
patients with ileal CD [28]. Genetic associations for Crohn’s
colitis patients overlap extensively with UC patients and differ
from ileal CD patients [29]. For example, the relative frequency
of patients with at least one of the three major NOD2 risk alleles
is only 16% in Crohn’s colitis patients, approaching the
frequency observed in non-IBD control subjects [30]. Subphe-
notyping CD patients with respect to disease location would
therefore facilitate biological interpretation of integrating meta-
genomic data with genotype data [31–33]. Another limitation of
the previous study was that relatively limited clinical metadata
was available for assessing the effects of potentially confounding
variables, such as obesity [34].
In the current study, 16S rRNA sequence analysis was
conducted on the proximal margins of resected ileum collected
from a larger independent set of subjects with and without
inflammatory disease to test the hypothesis that these genes affect
ileum-associated microbiota in grossly disease-unaffected regions of
the ileum, In contrast to the previous study, the subjects in the
current study were restricted to three disease phenotypes that were
unlikely to overlap with respect to disease location: 1.) Ileal CD
patients undergoing ileocolic resection; 2.) colitis patients (without
ileal disease) undergoing total colectomy or proctocolectomy; and
3.) control non-IBD patients undergoing either initial right
hemicolectomy or total colectomy. Patients with ileocolic anasto-
moses from previous surgeries were excluded, because increased
reflux of colonic luminal contents could potentially impact ileal
mucosal microbial profiles. The samples were also linked to far
more extensive clinical metadata than those used in the previous
exploratory analysis [5,11].
Because the previous dataset we analyzed was generated by
amplifying the entire 16S rRNA gene followed by Sanger
sequencing, this methodology was also applied in the current
study. However, to increase depth of coverage and corroborate
results derived from Sanger sequencing datasets, we also
performed 454 sequencing of two regions of the 16S rRNA gene
(V1–V3 and V3–V5) using primers adopted by the ongoing
Human Microbiome Project [35–38]. These three parallel datasets
provide a unique opportunity for comparing the results of these
three sequencing methods in a disease setting.
Materials and Methods
Patients and Acquisition of Macroscopically Disease-
Unaffected Proximal Margin Ileal Tissue Samples
This study was approved by the Institutional Review Boards of
Washington University-St. Louis and Stony Brook University. The
diagnosis of CD or UC was made ultimately on the basis of
pathological criteria (surgical resection specimen) [31–33]. Ileal
CD patients undergoing ileocolic resection, colitis patients
undergoing total colectomy and control non-IBD patients
undergoing either right hemicolectomy or total colectomy were
prospectively enrolled in a consecutive fashion by the Washington
University Digestive Diseases Research Core Center Tissue
Procurement Facility to donate surgically resected tissue samples
and clinical information between April 2005 and February 2010.
The clinical information and patient samples were stripped of all
identifying information and assigned a patient code and sample
code.
The ileal CD patients were predominantly those falling within
the Montreal classification of ileal disease with or without cecal
disease (L1) [30]. Based on post-operative pathological diagnosis of
the resected colon, 47 patients were diagnosed with UC, 9 patients
were diagnosed with Crohn’s colitis and 2 patients were diagnosed
with indeterminate colitis. Fifty-eight percent of the control non-
IBD patients underwent resection for benign colonic diseases
(colonic inertia, diverticulosis, adenomas, etc.) and the remaining
42% underwent resection for primary colonic adenocarcinomas.
Patients who were unwilling or unable to give informed consent
were excluded. Patients who had undergone previous resection of
ileum as evidence by the presence of an ileocolonic anastomosis
were excluded from this study. The number of subjects (n=170)
included in this cross-sectional study was designed to exceed the
number of subjects studied previously (n=125) [5,11].
A minimum of 4 biopsies were taken from the macroscopically
disease unaffected proximal ileal margin of fresh pathological
specimens using Radial Jaw4 large-capacity biopsy forceps (Boston
Scientific, Natick, MA), immediately placed in RNA stabilization
solution (RNAlater, Applied Biosystems/Ambion, Austin, TX) and
archived at 280uC [39]. The designation of disease-unaffected was
based on the macroscopic appearance of the mucosa and the
surgical pathology report of the adjacent biopsies (‘‘no histopath-
ologic abnormality’’). The samples were de-identified and linked to
a detailed clinical database by a patient study code.
Information on potential confounding variables was obtained by
reviewing the medical records, including the pathological report of
the resected intestine by a gastroenterologist (EL). Preoperative
mechanical bowel preparations were not routinely ordered,
particularly for the IBD patients. Also, adherence to bowel
preparations was quite varied among participating subjects. For
this reason, preoperative bowel preparation was not included in
the analysis. A smoker was defined as smoking $7 cigarettes a
week for at least a year [40–42]. The body mass index (BMI) was
recorded for all individuals [34]. Concomitant Clostridium difficile
infection was recorded as the presence of a positive fecal C. difficile
toxin [43,44]. Most of these patients were treated with metroni-
dazole or oral vancomycin [45]. All of the patients received
intravenous antibiotic prophylaxis covering both aerobic and
anerobic bacteria (e.g. ciprofloxacin and metronidazole, cefoxitin,
cefotetan) within one hour of incision [46].
Genotyping of NOD2 and ATG16L1 Single Nucleotide
Polymorphisms (SNPs)
Each patient was genotyped for the three major NOD2 SNPs,
Leu1007fsInsC (rs2066847, SNP13), R702W (rs206884, SNP8)
and G908R (rs2066845, SNP12) and for the autophagy like
ATG16L1T300A SNP (rs2241880) by direct sequencing, and/or
by a TaqMan MGB (Applied Biosystems, Foster City, CA)
genotyping platform using genomic DNA prepared from periph-
eral blood and/or tissue by the Sequenom Technology Core
within the Washington University Division of Human Genet-
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viously described [39]. Because some combinations of individual
NOD2 risk alleles, ATG16L1 risk alleles, and disease phenotype
were not sampled in this study, the three NOD2 risk alleles were
combined to form two composite categories: 1) NOD2
NR, subjects
harboring none of the three risk alleles (i.e., NOD2
NR/NR); or 2)
NOD2
R, subjects harboring at least one of the three risk alleles
(i.e., NOD2
R/R + NOD2
R/NR). The three ATG16L1 genotype
categories were: 1.) ATG16L1
NR/NR, no ATG16L1 risk allele; 2.)
ATG16L1
R/NR, a single ATG16L1 risk allele; 3.) ATG16L1
R/R,
two ATG16L1 risk alleles.
Library Construction and 16S rRNA Sequence Analysis
Parallel sequence datasets were generated for each of the
samples at the Genome Institute at Washington University as
previously described by 1.) broad-range PCR amplification of
bacterial rRNA genes and Sanger sequencing and 2.) 454
sequencing of two separate segments of the 16S rRNA gene that
encode either the V1 and V3 (V1–V3) or V3, V4, and V5 (V3–V5)
hypervariable regions (see Methods S1) [35–37]. Of note, the 454
sequencing primers used in this current study were identical to the
primers employed for characterizing the microbial communities in
healthy individuals at different body sites, including the gastroin-
testinal tract by the Human Microbiome Project (http://hmpdacc.
org/). The analysis software used to process the sequencing data
consisted of established function specific tools that are described in
greater detail in Methods S1. All sequences were screened for
fidelity to a 16S rRNA bacterial covariance model (CM) based on
secondary structure using the Infernal software package and were
checked for chimerism with ChimeraSlayer [37,47]. Potentially
chimeric sequences and sequences lacking high fidelity to the CM
were removed from subsequent analysis. Patient DNA samples
with less than 100 total screened sequences were excluded from
the analysis.
The sequences were classified into seven phyla/subphyla
categories using the Naı ¨ve Bayesian Classifier of the Ribosome
Database Project as described in Methods S1 [5,11]: The seven
categories were 1) Actinobacteria,2 )Bacteroidetes,3 )Firmicutes.
Clostridium Group IV, 4) Firmicutes. Clostridium Group XIVa,
5.) Firmicutes. Bacillus, 6.) Proteobacteria, and 7.) Other taxa. The
subdivisions of the Firmicutes phyla were based on concordance
between the RDP classifier and the Greengenes 16S rRNA
phylogenetic schema [5,11,48–51]. Six of these seven bacterial
categories (Actinobacteria, Bacteroidetes, Firmicutes/Clostridium
GroupIV, Firmicutes/Clostridium GroupXIVa, Firmicutes/Bacil-
lus, and Proteobacteria) were selected as representing the overall
microbial composition.
Assembled Sanger sequences were deposited in GenBank
accession HQ739096-HQ821395. 454 V1–V3 and V3–V5
sequences were deposited in the Sequence Read Archive
accession SRX021348-SRX021368, SRX037800-SRX037802.
Clinical and genotyping data can be accessed through the
dbGAP authorized access system. Request access to: phs000255.
The study accession is SRP002479 ‘‘Effect of Crohn’s disease
risk alleles on enteric microbiota’’. In order to request access to
any of the individual-level datasets within the controlled-access
portions of the database, the Principal Investigator (PI) and the
Signing Official (SO) at the investigator’s institution will need to
co-sign a request for data access, which will be reviewed by an
NIH Data Access Committee at the appropriate NIH Institute
or Center https://dbgap.ncbi.nlm.nih.gov/aa/wga.
cgi?page=login.
Quantitative PCR (qPCR)
QPCR assays were performed for the Clostridium coccoides –
Eubacterium rectales Faecalibacterium prausnitzii and total bacteria
using established primers (see Methods S1) [52,53]. The assays
were carried out in triplicate. Plasmid quantification standards
were prepared from representative clones of the target
organisms.
Statistical Analysis
Genotype and clinical categorical variables (e.g. disease
phenotype, smoking, etc.) were compared between disease
phenotypes using chi-square test for contingency tables. Clinical
continuous variables, such as age and body mass index (BMI)
were compared between disease phenotypes using the Kruskal-
Wallis test. The relative frequencies of six of seven (excluding
Other Taxa) categories selected to represent the overall
microbial composition, were adjusted by adding 0.5 to all raw
sequence counts in order to avoid 0% frequencies, and then
subjected to centered log ratio transformation for the analysis of
compositional data (see Methods S1) [54]. The effect of the
independent variables and all first order interactions on these six
bacterial categories (represented as a single vector), was
analyzed in parallel for each sequencing platform by permuta-
tion based multivariate analysis of covariance (MANCOVA)
with stepwise variable selection using the adonis function in R
software (Version 2.12.1) package vegan (Version 1.17-2),
Euclidean distances and a threshold significance level of 0.05
[55,56]. To address the multiple comparison issue, we applied
the Benjamini-Hochberg method to adjust P-values to the false
discovery rate (FDR) [57]. The effect of these independent
variables and their first order interactions on individual bacteria
categories was further analyzed by permutation based analysis
of covariance (ANCOVA) with stepwise variable selection and a
threshold significance of 0.05 [32,55,56]. Repeated measures
ANCOVA was then used to assess the union of the variables
and first order interactions selected by the parallel ANCOVAs
conducted on the three sequencing platforms separately, in an
effort to utilize all three data sets simultaneously [58,59]. The
empirical logit transformations of the relative frequencies of the
C. coccoides – E. rectales and the F. prausnitzii groups (measured by
targeted qPCR) was used in the permutation-based ANCOVA.
The Benjamini-Hochberg method was used to adjust P-values to
the false discovery rate (FDR) [57]. The R codes are provided
in Methods S1.
Results
Distribution of NOD2 and ATG16L1 Genotypes and
Clinical Characteristics of Ileal CD, Colitis, and Non-IBD
Control Subjects
As shown in Table 1, with the exception of race and gender,
there were differences (FDR #0.05) in the distribution of the 11
remaining variables between the three disease phenotypes. For
example, subjects who harbored at least one NOD2 risk allele,
NOD2
R, were more prevalent among ileal CD patients
[16,17,39]. Only two (4%) ileal CD patients were ATG16L1
NR/
NR Ileal CD patients were younger than the control patients at the
time of surgery [23]. Actively smoking subjects were less prevalent
in colitis patients [39–41]. The median BMI and age were lower in
ileal CD subjects. C. difficile was more prevalent among subjects
with colitis [43,45]. None of the control subjects were treated
with5-ASA, immunomodulators, and/or anti-TNFa biologics. All
of the patients received intravenous antibiotic prophylaxis that
Ileum Associated Microbiome in IBD
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prior to incision [46].
Comparison of the Relative Frequencies of Phyla/
Subphyla Bacterial Categories between Ileal CD, Colitis
and Control Disease-Unaffected Ileal Samples
Using the Sanger method, a total of 81,644 near full length 16S
rRNA sequences with acceptable quality were obtained with an
average of 500 reads/sample. A total of 1,191,278 454 V1–V3
sequences (mean 7260 reads/sample) and a total of 917,900 454
V3–V5 sequences (mean 5400 reads/sample) were obtained from
disease-unaffected samples. Greater than 90% of the sequences were
binned into six of seven phyla/subphyla categories as shown in
Figure 1. The Clostridium Group IV and Group XIVa taxa
correspond to two prominent subsets of the ‘‘Lachnospiraceae’’
taxonomic group previously discussed by Frank et al. [5,11]. As
shown in Figure 1, and Table S1, the distribution of relative
frequencies of the phyla/subphyla bacterial categories between the
three disease phenotypes (ileal CD, colitis, control non-IBD) were
very similar between the three datasets.
Disease Phenotype, C. difficile and NOD2 Genotype are
Associated with Shifts in Overall Disease-Unaffected
Ileum-Associated Microbial Composition (MANCOVA)
The three sequence datasets were analyzed in parallel using a
vector that combined the relative iesof the six most prevalent of
the seven phyla/subphyla categories (see Figure 1) as the
dependent variable. Exploratory permutation based MANCOVA
with stepwise variable selection including all first order interac-
tions, was conducted with each of the datasets. The parallel
analyses with each dataset selected disease phenotype among 13
variables, as associated (FDR #0.05) with overall changes in the
composition of mucosal bacterial communities (see Table 2). In
addition, C. difficile and NOD2 genotype were selected (FDR
#0.05) as associated with shifts in microbial composition. These
two variables had smaller effects (R
2) compared to the effect size
of disease phenotype. Repeating the analysis with the 150
Caucasian subjects yielded similar results (see Table S2).
Repeating the analysis after excluding subjects diagnosed with
Crohn’s colitis and indeterminate colitis also yielded similar
results (see Table S3).
Disease Phenotype Is Associated with Shifts in the
Relative Frequencies of Actinobacteria, Bacteroidetes,
Firmicutes. Clostridium GroupIV and Firmicutes. Bacillus
Categories
In order to explore whether these variables were associated
with particular microbial groups, permutation based ANCOVA
with stepwise variable selection was carried out in parallel for
each of the three datasets for each of the six phyla/subphyla
categories (see Table S4). The union of the significant
independent variables and first order interactions identified by
these parallel analyses was then reanalyzed by permutation
based repeated measures ANCOVA, in which the data from
each sequence dataset was treated as a repeated measure (see
Table 3). Analyzing the three datasets in parallel and as
repeated measures (See Table 3 and Table S4), disease
phenotype was selected as associated (FDR #0.05) with shifts
in the relative frequencies of four of the six phyla/subphyla
categories (Actinobacteria, Bacteroidetes, Firmicutes. Clostridium
GroupIV and Firmicutes.Bacillus). Repeated measures AN-
COVA also provided a means of comparing the results of the
three sequencing methods. The three sequencing methods
demonstrated good agreement (FDR.0.05) for the Actinobac-
teria and Bacteroidetes categories. Differences between the three
sequencing methods may have the biggest effect (R
2=0.040) on
assessing the relative frequency of Proteobacteria.
Table 1. Distribution of NOD2 composite and ATG16L1 genotype and clinical characteristics of ileal CD, colitis and control non-IBD
patients.
Variables Ileal CD (n=52) Colitis (n=58) Control (n=60) P-value FDR
NOD2
R (R/R + R/NR) 38% 15% 12% 0.003 0.004
ATG16L1T300A (NR/NR) 4% 28% 23% 0.006 0.007
Gender (male) 48% 57% 38% 0.130 0.14
Race (Caucasian) 92% 90% 83% 0.316 0.32
Median age (range) y 33 (18–72) 42 (17–68) 60 (32–64) ,0.001 ,0.001
Current smoker 33% 3% 25% 0.003 0.004
Positive fecal C. difficile toxin 6% 28% 0% ,0.001 ,0.001
Median BMI (range) kg/m
2 24 (16–41) 25 (16–45) 28 (18–47) 0.006 0.007
5-ASA 52% 59% 0% ,0.001 ,0.001
Steroids 54% 72% 0% ,0.001 ,0.001
Immunomodulators 44% 72% 0% ,0.001 ,0.001
Anti-TNFa biologics ,0.001 ,0.001
Current (#8 weeks of surgery) 29% 29% 0%
Past (.8 weeks of surgery) 6% 7% 0%
Never 65% 64% 0%
The variables shown above are included in the subsequent MANCOVA and ANCOVA analyses. Chi-square test for contingency table was used for categorical data and
Kruskal-Wallis test was used for age and BMI. To address multiple comparison issues, the Benjamini-Hochberg method was applied to adjust P-values to the false
discovery rate (FDR).
doi:10.1371/journal.pone.0026284.t001
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Rectales and Fecalibacterium Prausnitzii by qPCR
QPCR analyses were conducted on total bacteria, the C.
coccoides-E. rectales group and F. prausnitzii using previously
established primers (see Figure 2).
52–53 The relative frequency of
the C. coccoides-E. rectales group, which overlaps the ‘‘Lachnospiraceae’’
taxonomic group (Clostridium GroupIV and XIVa are prominent
subsets) was previously shown to be reduced in a subset of IBD
subjects.
5 F. prausnitzii is a major species within the Clostridium
Group IV category. Low relative frequency of F. prausnitzii has
been reported to be reduced in patients with ileal CD and has
been associated with an increased risk of ileocolonoscopic
recurrence of ileal CD [8,9,12].
As shown in Figure 2, the relative frequency of the C. coccoides-E.
rectales group was significantly higher in NOD2
R ileal CD subjects
than in NOD2
NR ileal CD subjects. In contrast, the relative
frequency of the C. coccoides-E. rectales group was lower in ileal CD
subjects compared to control non-IBD subjects, consistent with
previous analysis of an independent set of tissues [5]. As shown in
Table 4, IBD phenotype, NOD2 genotype and IBD medications
were selected by ANCOVA with stepwise variable selection as
associated (FDR #0.05) with shifts in the relative frequency of C.
coccoides-E. rectales group. First order interactions between IBD
phenotype and race, and between NOD2 genotype and steroids,
were also selected. Unfortunately 13 DNA samples were exhausted
before the qPCR assays for F. prausnitzii were conducted, reducing
the total samples analyzed from 170 to 157. IBD phenotype,
smoking and steroids were selected by ANCOVA with stepwise
variable selection as associated (FDR #0.05) with shifts in the
relative frequency of F. prausnitzii (see Table 4). First order
interactions between NOD2 and smoking, and between age and
gender were also selected.
Comparison of Non-IBD Control Samples from Subjects
with and without Primary Colon Adenocarcinoma
Because a major proportion (42%) of the non-IBD control
subjects underwent surgery for resection of right sided primary
colon adenocarcinoma, we performed exploratory analyses
comparing the relative frequencies of the seven phyla/subphyla
clades as well as other clinical variables. As shown in Table S5, the
only variable that was different (FDR #0.05) between the two
groups of patients was the age of surgery, which is consistent with
the observation that the incidence of colon cancer increases with
patient age [60].
Discussion
In this study we report the results of multiple regression analysis
of the largest 16S rRNA sequence datasets reported thus far on
ileal tissues collected from IBD subjects. This analysis demon-
strates that IBD phenotype has a predominant effect on microbial
composition associated with the macroscopically normal appear-
ing proximal margin of resected ileum. The changes in intestinal
microbiota that were observed in ileal CD may have occurred
early in the pathogenic process before overt disease was manifest.
Alternatively, chronic enteric dysbiosis that arises as a conse-
Figure 1. Phyla/subphyla comparison of three disease phenotypes (ileal CD, colitis, using the Sanger, 454 V1–V3 and 454 V3–V5
data sets. The average relative frequency of each taxa is shown for ileal CD, colitis and control subjects for each of the three sequencing data sets,
(see also Table S1 for means 6 standard deviations).
doi:10.1371/journal.pone.0026284.g001
Ileum Associated Microbiome in IBD
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tract may be propagated to unaffected sites. The observed
alterations in ileal microbiota could have an impact on regional
inflammation or metabolic properties (e.g., butyrate metabolism),
however the functional implications of these shifts remain to be
determined.
NOD2 genotype was also selected albeit with more modest
effect for all three 16S rRNA sequence datasets and for targeted
qPCR assays of the C. coccoides- E. rectales group. The bacterial
16S rRNA sequences assayed by the C. coccoides – E. rectales
qPCR assay likely overlap with some but not all the 16S rRNA
sequences included in Group XIVa and IV. The observation
that ileal CD phenotype and NOD2 risk alleles, which
presumably contribute to this phenotype, had opposite effects
on this microbial group, suggests that the effect of the NOD2
risk allele on the relative frequency of the C. coccoides-E. rectales
group is not simply mediated through an association with ileal
CD phenotype. Thus the results of targeted QPCR assays and
16S rRNA sequence analysis both demonstrate a significant
effect of NOD2 genotype on ileum associated microbial
composition. Our results in disease –unaffected ileal tissues
Table 2. Permutation based MANCOVA with stepwise
variable selection results for Sanger, 454 V1–V3 and 454 V3–
V5 sequencing.
Sequencing Sanger (n=164)R
2 P value FDR
Main effects Disease phenotype 0.151 0.001 0.008
C. difficile 0.019 0.019 0.04
NOD2 0.018 0.011 0.03
Interactions Disease phenotype * 5-ASA 0.022 0.012 0.03
Steroids * Immunomodulators 0.022 0.006 0.03
Disease phenotype * Age 0.033 0.008 0.03
Sequencing 454 V1–V3 (n=164) R
2 P value FDR
Main effects Disease phenotype 0.126 0.001 0.008
C. difficile 0.019 0.016 0.03
NOD2 0.017 0.029 0.05
Interactions Disease phenotype * 5-ASA 0.022 0.011 0.03
Steroids * Immunomodulators 0.022 0.006 0.03
Disease phenotype * Age 0.032 0.009 0.03
Sequencing 454 V3–V5 (n=169) R
2 P value FDR
Main effects Disease phenotype 0.119 0.001 0.008
C. difficile 0.020 0.014 0.03
NOD2 0.029 0.004 0.02
Interactions Disease phenotype * 5-ASA 0.020 0.015 0.03
Steroids * Immunomodulators 0.030 0.001 0.008
NOD2 * ATG16L1 0.024 0.028 0.05
5-ASA * ATG16L1 0.024 0.040 0.06
The dependent variable was the vector generated by the centered log ratio of
the relative frequencies of six phyla/subphyla categories (see text). The
significant main effects and first order interactions selected by analysis of each
of the three data sets as well as the R
2, P values are listed here. To address
multiple comparison issues, the Benjamini-Hochberg method was applied to
adjust P-values to the false discovery rate (FDR). The number of samples
(total=170 samples) that yielded results suitable for analysis is listed for each
method.
doi:10.1371/journal.pone.0026284.t002
Table 3. Permutation-based repeated measures ANCOVA
results for each of the six phyla/subphyla bacterial categories
(Clade).
Category/
Clade ACTINOBACTERIA R
2 P value FDR
Main effects Disease phenotype 0.126 0.001 0.01
Steroids 0.021 0.029 0.08
Interactions Age of Surgery * ATG16L1 0.041 0.014 0.07
Measurements 0.001 0.328 0.47
Category/
Clade
BACTEROIDETES R
2 P value FDR
Main effects Disease phenotype 0.117 0.001 0.01
Smoking 0.018 0.034 0.09
5-ASA 0.021 0.025 0.08
Steroids 0.023 0.013 0.07
Interactions Steroids *
Immunomodulators
0.040 0.006 0.04
Disease phenotype * 5-ASA 0.019 0.023 0.08
5-ASA * Age 0.016 0.050 0.12
5-ASA * C. difficile 0.019 0.023 0.08
Measurements 0.002 0.047 0.12
Category/
Clade
FIRM.CLOSTRIDIUM GROUPIVR
2 P value FDR
Main effects Disease phenotype 0.161 0.001 0.01
Gender 0.038 0.003 0.02
Smoking 0.025 0.015 0.07
NOD2 0.021 0.027 0.08
Interactions Disease phenotype * Age 0.040 0.003 0.02
BMI * 5-ASA 0.025 0.010 0.06
Measurements 0.008 0.001 0.01
Category/
Clade
FIRM.CLOSTRIDIUM
GROUPXIVa
R
2 P value FDR
Main effects Gender 0.023 0.019 0.08
Interactions Disease phenotype * Age 0.049 0.004 0.03
Steroids * BMI 0.030 0.011 0.06
Measurements 0.006 0.006 0.04
Category/
Clade
FIRM.BACILLUS R
2 P value FDR
Main effects Disease phenotype 0.175 0.001 0.01
NOD2 0.016 0.046 0.12
Interactions Disease phenotype
* Steroids
0.040 0.002 0.02
Disease phenotype * Age 0.027 0.032 0.09
5-ASA * ATG16L1 0.025 0.025 0.08
Steroids * Immunomodulators 0.019 0.027 0.08
Measurements 0.008 0.001 0.01
Category/
Clade
PROTEOBACTERIA R
2 P value FDR
Main effects NOD2 0.027 0.016 0.07
Interactions Steroids * NOD2 0.040 0.002 0.02
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tissues that were more heterogeneous with respect to anatomic
location and inflammation. Our findings are consistent with the
report that the relative frequency of Firmicutes spp., as
determined by targeted qPCR, is higher in NOD2 knockout
mice than in wild type mice [20,21]. However, it is important
to note that the patient-based studies are not directly
comparable to the mouse studies because 1) the NOD2
knockout mouse may differ phenotypically from the NOD2Le-
u1007fs knock-in mouse [61], and 2) only 4% of the ileal CD
patients compared to 28% of colitis and 23% of control non-
IBD patients, were homozygous for the ATG16L1 T300A
nonrisk allele (ATG16L1
NR/NR). These findings are also
consistent with the recent report that the relative frequency of
Firmicutes measured by targeted qPCR is higher in three CD
patients that were homozygous for the Leu1007fs (SNP13)
compared to 11 CD patients that were homozygous for the wild
type allele [21]. Since only two of the ileal CD patients were
homozygous for the Leu1007fs allele in our dataset, a parallel
comparison could not be made (see Table S6).
C. difficile infections, particularly recurrent C. difficile infections
have been associated with altered fecal microbial composition
[62,63]. Patients with inflammatory bowel diseases are more likely
to develop C. difficile infections, which are also associated with
clinical exacerbation of their disease [43,44]. It is possible that the
shifts in microbial composition associated with IBD contribute to
these patients’ susceptibility to C. difficile and other infections that
may exacerbate inflammation. Alternatively antibiotic treatment
of subjects with C. difficile could contribute to the observed shifts in
microbial composition [64,65].
Sanger sequencing of the entire 16S rRNA gene permits
accurate phylogenetic identification of bacteria, whereas 454
pyrosequencing generates much greater depth of coverage, but
with lesser phylogenetic resolution. While the results of all three
sequencing methodologies demonstrated associations of disease
phenotype, C. difficile infection and NOD2 genotype to the overall
microbial composition in parallel analyses, they differed with
respect to the main effects and first order interactions associated
with individual phyla/subphyla categories. Methodological differ-
ences may reflect biases introduced during the initial PCR
amplification step, as noted by Olsen and coworkers for the 27F
forward primer [66]. In addition, there are likely differences in the
phylogenetic resolution/assignment of the complete 16S sequence
as opposed to different hypervariable regions (V1–V3 and V3–V5)
of the gene sequence. Although the results from each sequencing
method may converge with increasing the sample size, differences
in the microbial composition data generated by different
sequencing methods will make it challenging to compare results
from studies using different primers for the initial PCR amplifi-
cation.
The F. prausnitzii 16 S rRNA sequences assayed by targeted
qPCR form a major subset of all the sequences grouped within the
Firmicutes.Clostridium Group IV clade. The selection of smoking
as a potentially significant covariate is intriguing, since smoking
has been associated with ileal CD phenotype and with early
postoperative recurrence in ileal CD patients, and is consistent
with the observations of Sokol and coworkers that low ileal
mucosal concentrations of F. prausnitzii is associated with early
Table 3. Cont.
Category/
Clade ACTINOBACTERIA R
2 P value FDR
5-ASA * Race 0.032 0.007 0.04
Steroids * Immunomodulators 0.021 0.030 0.08
NOD2 * ATG16L1 0.056 0.019 0.08
Measurements 0.040 0.001 0.01
Sequencing results for all three platforms were available for 157 samples (44
ileal CD, 53 colitis and 60 control non-IBD). The variables and first order
interactions with P#0.05 are listed above. To address multiple comparison
issues, the Benjamini-Hochberg method was applied to adjust P-values to the
false discovery rate (FDR). The variables and first order interactions with FDR
#0.05 are bolded.
doi:10.1371/journal.pone.0026284.t003
Figure 2. Targeted qPCR results for the C. coccoides-E. rectales
group and for F. prausnitzii spp. Boxplots of (panel A) the log2 C.
coccoides-E. rectales group/total bacteria and (panel B) the log2 F.
prausnitzii/total bacteria as a function of disease phenotype and NOD2
genotype assayed using qPCR are shown. The middle line represents
the median, and the lower edge and the upper edge of the box
represent the 25% and 75% quartiles. The bottom and top lines
represent the minimum and maximum values, respectively. For the C.
coccoides-rectales group, all 170 samples were assayed. For F. prausnitzii,
157 of 170 samples were assayed.
doi:10.1371/journal.pone.0026284.g002
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Smoking was also selected by analysis of the Sanger and
454V1–V3 datasets as significantly associated with shifts in relative
frequency of the Firmicutes.Clostridium Group IV clade (Table
S4). Smoking cessation has clearly been linked to altering the
subgingival microbial profile [67], but has not been previously
linked to altering the ileum associated microbial profile.
Although pathologic review of the resected tissues provided
rigorous phenotyping of the samples, the use of surgically resected
tissues may bias the results by sampling of IBD patients with
relatively severe disease who have been treated for various lengths
of time with antibiotics and different IBD medications. Although
the focus of this study was ileal CD, it is likely that other human
diseases will exhibit similar links between genetically determined
defects in mucosal immunity and alterations of resident microbi-
ota. As we further expand these datasets by analyzing more
samples, we anticipate that further associations between microbial
composition, IBD subphenotypes, IBD polymorphisms and
environmental factors will emerge.
Supporting Information
Table S1 A. Relative frequencies of the six phyla/
subphyla categories selected to represent overall micro-
bial composition based on the Sanger dataset. The mean
value 6 standard deviation is shown for each of the three disease
phenotypes, ileal CD, colitis and control non-IBD. B. Relative
frequencies of the six phyla/subphyla categories select-
ed to represent the overall microbial composition based
on the 454 V1–V3 dataset. The mean value 6 standard
deviation is shown for each of the three disease phenotypes, ileal
CD, colitis and control non-IBD. C. Relative frequencies of
the six phyla/subphyla categories selected to represent
the overall microbial composition based on the 454 V3–
V5 dataset. The mean value 6 standard deviation is shown for
each of the three disease phenotypes, ileal CD, colitis and control
non-IBD.
(DOCX)
Table S2 Permutation-based MANCOVA with stepwise
variable selection results for Caucasian patients. Because
NOD2 risk alleles are rarely observed in subjects of Asian and
African descent, the analysis was repeated for the 150 Caucasian
subjects in the study (48 ileal CD, 52 colitis, 50 non-IBD control
subjects). The dependent variable was the vector generated by the
centered log ratio of the relative frequencies of six phyla/subphyla
categories (see text). The significant main effects and first order
interactions selected by analysis of each of the three data sets as
well as the R
2, P values are listed below. To address multiple
comparison issues, the Benjamini-Hochberg method was applied
to adjust P-values to the false discovery rate (FDR). The number of
samples (total=150 samples) that yielded results suitable for
analysis is listed for each method.
(DOCX)
Table S3 Permutation-based MANCOVA with stepwise
variable selection results for Sanger, 454 V1–V3 and 454
V3–V5 sequencing. Samples with Crohn’s colitis and indeter-
minate colitis were excluded in this analysis. The dependent
variable was the vector generated by the centered log ratio of the
relative frequencies of six phyla/subphyla categories (see text). The
significant main effects and first order interactions selected by
analysis of each of the three data sets as well as the R
2, P values are
listed below. To address multiple comparison issues, the
Benjamini-Hochberg method was applied to adjust P-values to
the false discovery rate (FDR). The number of samples (around
150 samples) that yielded results suitable for analysis is listed for
each method.
(DOCX)
Table S4 Permutation based ANCOVA with stepwise
variable selection results for each of the six individual
phyla/subphyla categories. Permutation based ANCOVA
with step wise variable selection was carried out for the individual
phyla/subphyla categories. in parallel for each of the datasets. A
total of 164 samples were analyzed for the Sanger and the 454
V1–V3 datasets respectively. A total of 169 samples were analyzed
for the 454 V3–V5 dataset. Listed below are the main effects, first
order interactions with P-values #0.05, as well as the main effects
of first order interactions with P values #0.05. To address multiple
comparison issues, the Benjamini-Hochberg method was applied
to adjust P-values to the false discovery rate (FDR). The main
effects and first order interactions with FDR #0.05 are bolded.
(DOCX)
Table S5 Comparison between nonIBD control subjects
with primary colon adenocarcinoma with non-IBD
subjects without primary colon adenocarcinoma. Con-
tinuous variables (e.g. age, BMI, relative frequency of bacterial
groups) were compared using the Wilcoxon rank sum test and
categorical variables (e.g. genotype, smoking, race) were compared
using the chi-square test. Note that none of the non-IBD control
subjects had a positive C. difficile toxin or were taking any IBD
medications. To address multiple comparison issues, the Benja-
Table 4. ANCOVA with stepwise variable selection results for
relative frequencies of the C. coccoides-E. rectales microbial
group and F. prausnitzii spp. based on targeted qPCR assays.
Category C. coccoides-E. rectales n=170 R
2 P value FDR
Main effects Disease phenotype 0.06368 0.001 0.006
NOD2 genotype 0.08250 0.001 0.006
Anti-TNFa 0.08216 0.001 0.006
ASA 0.02904 0.009 0.02
Immunomodulator 0.02548 0.019 0.03
Race 0.01050 0.125 0.16
Steroids 0.00002 0.954 0.95
Interactions Disease phenotype * Race 0.05563 0.003 0.01
NOD2 * steroids 0.02605 0.056 0.03
Category F. prausnitzii n=157 R
2 P value FDR
Main effects Disease phenotype 0.0662 0.002 0.008
Smoking 0.0284 0.018 0.03
Steroids 0.0270 0.017 0.03
NOD2 0.0033 0.394 0.48
Age 0.0020 0.500 0.51
Gender 0.0025 0.456 0.52
Interactions Smoking * NOD2 0.0528 0.004 0.01
Age * Gender 0.0274 0.019 0.03
See Materials and Methods. The variables and first order interactions with
significant P values (#0.05) as well as the variables in the first order interactions
are listed above. To address multiple comparison issues, the Benjamini-
Hochberg method was applied to adjust P-values to the false discovery rate
(FDR). The variables and first order interactions with FDR #0.05 are bolded.
doi:10.1371/journal.pone.0026284.t004
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discovery rate (FDR). Variables with FDR #0.05 are bolded.
(DOCX)
Table S6 Distribution of the three common NOD2
genotypes in ileal CD, colitis and non-IBD control
subjects. The three major NOD2 risk alleles that account for
80% of the NOD2 variants, are Leu1007fs (SNP13, rs2066847),
R702W (SNP8, rs2066844), and G908W (SNP12, rs2066845).
(DOCX)
Methods S1
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